Mumbai, Apr 17 (UNI) To neutralise the acid in stomach alongwith acid in food pipe (oesophagus) Glaxo SmithKlime(GSKCH) has introduced a new variant of 'Eno' - 'Eno Pudina' in select Indian markets.
With this launch GSKCH India has expanded its portfolio of products in the antacid segment.
Eno Pudina has been demonstrated to neutralise acid, both in the stomach as well as refluxed acid in the oesophagus(food-pipe). It has been shown that other antacids only neutralise the acid in the food-pipe, and not the stomach. This feature of Eno Pudina makes it a natural choice for fast and effective relief, a company release issued today said.
According to company manager, Trupti Bhandari, ''Pudian has a long heritage of use as a carminative in digestive disorders. The main ingredients of Eno pudina are 'Svarjikshara' and 'Nimbukamlam' which provide the fast action while Pudina provides the benefits of cooling and numbing the oesophagus, enhancing the perception of reief.'' The launch of pudina variant is expected to expand the market for antacids and enhance the equity of brand ENO. This is a pan India launch covering the North, West, East and key markets of South.
UNI VS PP AW1858